Skip to main content

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

Feedback
Newsletter
RSS
Twitter

User Top Menu

Welcome, guest
Log In
Join
Why Join?

Search form

Search

About Us
- Overview
- Who We Are
- Contact
- Fan Mail
- How to Cite
News & Future Directions
Papers
Forums
- Discussions
- Webinars
Professional Resources
Research Resources
Click Here to Support MSDF

You are here

Most Viewed

Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.
Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner.
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial.
Synthetic Biologics announces issuance of U.S. patent covering combination of estriol and Copaxone® for multiple sclerosis
endMS CONFERENCE
Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis.
Episode 29 with Dr. Monica Carson on MS research funding
“Human Medicines” page
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis.
Episode 32 with Dr. David Holtzman on the connection between MS and Alzheimer 's disease
Covis Pharma to Acquire U.S. Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate®
Breastfeeding and multiple sclerosis relapses: a meta-analysis.
Aubagio® significantly reduced risk of new clinical relapse or MRI lesion in multiple sclerosis study
Bilateral optic neuritis in a patient with Behçet's disease who respond to therapeutic plasma exchange.
European School of Neuroimmunology 15th Course
JOINT CONGRESS OF EUROPEAN NEUROLOGY
Avonex approval application
Free MED IQ Live CME Event on Multiple Sclerosis Nov 22nd
Dimethylfumarate Impairs Neutrophil Functions.
Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome.
Randomized study combining interferon & glatiramer acetate in multiple sclerosis.
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
MSGene
Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.

Pages

« first
‹ previous
…
60
61
62
63
64
65
66
67
68
…
next ›
last »

MSDF Footer

Copyright © 2014 MGH and ACP

Privacy
Terms of Use
How to Cite
FAQ/Help
Site Map
Support Us
Feedback
Image Credits

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Content By

Software By